Paying for promising but unproven technologies

AUTOR(ES)

Kamerow, Douglas

FONTE

BMJ Publishing Group Ltd.

RESUMO

Is the policy on “coverage with evidence development” a helpful way forward?

Documentos Relacionados

• Paying for bmj.com: Move is understandable but sad end to a decade
• Collaboration with the FDA promising but problematic
• Paying for statins
• Paying for the view
• Paying for bmj.com